iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Shares Up 0.5% – Here’s Why

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRNGet Free Report) shot up 0.5% during mid-day trading on Wednesday . The stock traded as high as $23.81 and last traded at $23.81. 336 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 601 shares. The stock had previously closed at $23.68.

iShares Neuroscience and Healthcare ETF Stock Performance

The firm has a market cap of $3.57 million, a P/E ratio of 28.31 and a beta of 0.72. The firm has a fifty day moving average of $25.19 and a 200-day moving average of $25.76.

Institutional Trading of iShares Neuroscience and Healthcare ETF

An institutional investor recently bought a new position in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC purchased a new position in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRNFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned about 6.77% of iShares Neuroscience and Healthcare ETF at the end of the most recent quarter.

iShares Neuroscience and Healthcare ETF Company Profile

(Get Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.

Read More

Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.